Deciphera, a commercial biopharmaceutical company, is decoding cancer at the molecular level by leveraging its proprietary platform to develop a diverse pipeline of drug candidates designed to improve outcomes for patients. The Company received its first FDA-approved medicine in May 2020, visit our product website at https://qinlockhcp.com/ for more information.
Featured Content
